Marijn Dekkers

Apr 16, 2019

Marijn Dekkers has been named chairman of the board of synthetic biology firm Ginkgo Bioworks. He also will serve as a strategic advisor of the Boston-based company. Dekkers most recently served as CEO of Bayer AG, and prior to that was CEO of Thermo Fisher Scientific. He also currently serves as chairman of Unilever and is founder and chairman of Novalis LifeSciences, a boutique investment and advisory firm.

Breaking News

Cerebral Palsy Sequencing Study Finds Clinically Actionable Alterations
Lucid Diagnostics Raises $22M in Convertible Debt Refinancing
Medicover Genetics Receives IVDR Certification for Genetic Testing Reagent Kit
Final FDA Guidance Lays Path for Drugmakers to Establish Circulating Tumor DNA as Trial Endpoint
Multi-Ancestry Study Uncovers Genetic Contributors to Progressive Eye Disease

Marijn Dekkers

Cerebral Palsy Sequencing Study Finds Clinically Actionable Alterations

Lucid Diagnostics Raises $22M in Convertible Debt Refinancing

Medicover Genetics Receives IVDR Certification for Genetic Testing Reagent Kit

Final FDA Guidance Lays Path for Drugmakers to Establish Circulating Tumor DNA as Trial Endpoint

Multi-Ancestry Study Uncovers Genetic Contributors to Progressive Eye Disease